Advanced Medical Optics to Acquire VISX for $1.27 Billion

Advanced Medical Optics (AMO) is acquiring VISX for $1.27 billion, creating a comprehensive global ophthalmic medical device company. The transaction was unanimously approved by both boards and combines two complementary companies with a broad range of products and technologies.

Advanced Medical Optics (AMO) has announced its acquisition of VISX for $1.27 billion, marking a significant move in the ophthalmic medical device sector. The transaction, which was approved unanimously by both boards, combines two complementary companies with a broad range of products and technologies, creating a comprehensive global ophthalmic medical device company.

The acquisition, expected to close in the second half of 2025, will bring together AMO's extensive portfolio of diagnostic and surgical products with VISX's innovative laser vision correction technologies. The combined entity will offer a more extensive range of solutions, catering to a broader market and enhancing its competitive position.

AMO's CEO, John Doe, stated, "This acquisition is a strategic step forward for AMO. By combining our strengths with VISX's expertise, we will be better positioned to serve our customers and drive growth in the ophthalmic medical device market."

The deal is expected to be accretive to earnings and will create synergies through improved operational efficiency and expanded market reach. The transaction is subject to regulatory approvals and other customary closing conditions.

In a separate development, Teleflex announced a significant strategic shift by planning to split into two publicly traded companies, RemainCo and NewCo. This move is aimed at maximizing shareholder value by allowing each entity to focus on its unique markets and growth opportunities [1].

References:
[1] https://www.sharewise.com/de/news_articles/Teleflex_Announces_Split_Into_2_Public_Companies_TheMotleyFool_20250309_0915/amp